Skip to content

DR. EERSELS

Active Private limited company (pre-2019)founded 1999active for 27 yearsRozenkranslaan 98, 3600 GenkKBO/BCE: BE 0465.570.801

Lifetime

19 annual accounts with figures on one time axis, 26 filings since 2000
peak of €624,581 in 2019
€281,193▼ 14.2%
lowest -€21,154 in 2008
€116,179▼ 34.1%
peak of €1.2m in 2020
€1.0m▼ 2.5%
€169,973▼ 30.7%
peak of 1 FTE in 2007
-not published
Board1 name since 2012
1 director
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Gross margin from €327,701 to €281,193Result from €176,341 to €116,179Dividend €142,690Debts from €245,170 to €169,973Cash from €105,706 to €394,395

Key points

from the 2025 annual accounts

Equity

€1.0m ▼ 2.5%
1.02024+0.1Profit-0.1Dividend1.02025

DR. EERSELS paid out €142,690 in dividends. That is 123% of the 2025 profit.

Result

€116,179 ▼ 34.1%
€176,0002024€116,0002025

The result fell in 2025 from €176,341 to €116,179.

Turnover

≈ €430,000 estimated

The micro format states no turnover.

Liquidity

7.44 was 4.76 in 2024

Short-term debts fell from €122,855 to €72,729.

Filings

26 annual accounts since 2000
AprilJune31 JulyOctober200020102020

Seven of the last ten came late. The 2019 accounts came in latest, 91 days after the end of the period.

Position in the sector

€1.0m

More equity than 94% of companies in human health. The sector median is €125,227, over 21,375 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as DR. EERSELS has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for DR. EERSELS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • deed of 23-04-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0465570801
Capital decrease of €210,354.06 to €18,600 The capital fell from €228,954.06 to €18,600, cancelling 992 shares · Gazette deed
Capital increase of €210,354.06 to €228,954.06 The capital rose from €18,600 to €228,954.06, with 992 new shares · Contribution by · General meeting of 17-03-2014 · Gazette deed
appointed as manager General meeting of 26-12-2012 · Gazette deed
All 42 events

Comparable companies

same main activity, similar in size and age
Company
DR. EERSELS Genk €1.2m €281,193 85.8% -
Dokterspraktijk Marc Busschots Sint-Truiden €1.2m €256,873 94.0% -
DOKTER LAUWERYS JOZEF Wingene €1.1m €284,216 73.2% -
Dokter Johan Crevits Kortemark €1.2m €287,251 94.1% -
VERLINDE FRANK Bredene €1.1m €274,334 98.2% -
VANDEREYKEN-GUBBELS Brasschaat €1.3m €261,163 90.8% -
DOKTER GUY COUCKE Ghent €1.1m €268,866 93.9% -

These companies have the same main activity as DR. EERSELS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.1m and €1.3m, founded between 1996 and 2000.

Official details

Source: KBO
Status
Active since 02-03-1999Normal situation
Activity
General medical practiceNACE 86210
Joint committee
330Health institutions and services · annual accounts 2025
Establishment unit
2.229.324.2743600 Genk, since 20-02-1999
Financial year end
31 December
Peppol
Reachable since 31-12-2025
Company details

Annual accounts 2025

€1.2m▼ 7.9%
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on DR. EERSELS

DR. EERSELS files the micro format. That format states no turnover. The gross margin rose from €89,499 in 2007 to €281,193 in 2025.

The balance sheet grew most in 2011 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. EERSELS

What is the company number of DR. EERSELS?
The company number of DR. EERSELS is 0465.570.801. The VAT number is the same number with BE in front: BE 0465.570.801.
Where is DR. EERSELS based?
The registered office is at Rozenkranslaan 98, 3600 Genk.Company details
What does DR. EERSELS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. EERSELS?
DR. EERSELS is a private limited company (pre-2019) (BVBA).
When was DR. EERSELS founded?
DR. EERSELS was founded on 02-03-1999.
Is DR. EERSELS still active?
Yes, DR. EERSELS is an active enterprise in the KBO register.
How many employees does DR. EERSELS have?
DR. EERSELS had an average of 0.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does DR. EERSELS fall under?
In its 2025 annual accounts, DR. EERSELS states joint committee 330 (Health institutions and services).
What is the turnover of DR. EERSELS?
The turnover in financial year 2025 is about €430,000. This figure is estimated from the gross margin of €281,193 and 38 comparable companies (NACE 862). It probably lies between €370,000 and €540,000.
Is DR. EERSELS profitable?
In financial year 2025, DR. EERSELS made a profit of €116,179.
Where can I find the annual accounts of DR. EERSELS?
DR. EERSELS filed 26 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. EERSELS due?
DR. EERSELS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.